| Literature DB >> 33300232 |
Claudia Castiglioni1, François Feillet2,3, Christine Barnerias4, Arnaud Wiedemann2,3, Jordi Muchart5, Fanny Cortes6, Cristina Hernando-Davalillo7, Raquel Montero8,9, Thierry Dupré10,11, Arnaud Bruneel10,12, Nathalie Seta10, Sandrine Vuillaumier-Barrot10, Mercedes Serrano9,13.
Abstract
Signal sequence receptor protein 4 (SSR4) is a subunit of the translocon-associated protein complex, which participates in the translocation of proteins across the endoplasmic reticulum membrane, enhancing the efficiency of N-linked glycosylation. Pathogenic variants in SSR4 cause a congenital disorder of glycosylation: SSR4-congenital disorders of glycosylation (CDG). We describe three SSR4-CDG boys and review the previously reported. All subjects presented with hypotonia, failure to thrive, developmental delay, and dysmorphic traits and showed a type 1 serum sialotransferrin profile, facilitating the diagnosis. Genetic confirmation of this X-linked CDG revealed one de novo hemizygous deletion, one maternally inherited deletion, and one de novo nonsense mutation of SSR4. The present subjects highlight the similarities with a connective tissue disorder (redundant skin, joint laxity, blue sclerae, and vascular tortuosity). The connective tissue problems are relevant, and require preventive rehabilitation measures. As an X-linked disorder, genetic counseling is essential.Entities:
Keywords: SSR4; TRAP complex; congenital disorders of glycosylation; connective tissue disorders; translocon associated complex
Mesh:
Substances:
Year: 2020 PMID: 33300232 DOI: 10.1002/humu.24151
Source DB: PubMed Journal: Hum Mutat ISSN: 1059-7794 Impact factor: 4.878